Articles tagged with: British Columbia Centre for Excellence in HIV_AIDS

Patients with HIV six times as likely to have schizophrenia

published: March, 13, 2018 Written by // Guest Authors - Revolving Door Categories // Social Media, Mental Health, Health, International , Revolving Door, Media, Guest Authors

"... researchers indicated that time from schizophrenia diagnoses to death was significantly short for those with HIV than those without." From MD Mag, Kevin Kunzmann reports.

Patients with HIV six times as likely to have schizophrenia

There is a six-fold prevalence of schizophrenia in people with HIV than that of the population without the virus, according to the results of a Vancouver, BC, Canada-based study. The study, presented at the 25th Conference on Retroviruses and Opportunistic Infections (CROI) in Boston, MA, this week, found a distinct association between the mental disorder and HIV — a relationship sparsely analyzed before. Researchers from the British Columbia Centre for Excellence in HIV/AIDS in Vancouver,

Patterns of substance use associated with fentanyl exposure in Vancouver

published: March, 12, 2018 Written by // CATIE - HIV and Hep C Info Resource Categories // Social Media, Current Affairs, Research, Health, CATIE - HIV and Hep C Info Resource, Media

From CATIE, Sean R. Hosein reports on a Vancouver study aiming to find out about the degree of exposure to fentanyl among people who use street drugs.

Patterns of substance use associated with fentanyl exposure in Vancouver

- British Columbia researchers analyzed urine samples of 669 people who used street drugs - 15% of all participants had been exposed to the extremely powerful opioid fentanyl - Exposure to fentanyl was higher among those who inject drugs In the past several years, deaths from opioid overdose have increased in Canada and the U.S. In Canada the increase in deaths was initially reported in British Columbia and then spread to neighbouring Alberta and other parts of Canada. British

Diabetes in people with HIV over 50 overwhelmingly linked to old antiretrovirals, not age or body weight

published: January, 04, 2018 Written by // Guest Authors - Revolving Door Categories // Social Media, Aging, Research, Health, International , Revolving Door, Media, Guest Authors

The onset of diabetes was much less likely in people aged 50 and over who started treatment from 2010 onwards, or who started treatment at a higher CD4 cell count, according to this B.C.study. From AIDSmap, Keith Alcorn explains.

Diabetes in people with HIV over 50 overwhelmingly linked to old antiretrovirals, not age or body weight

People with HIV over the age of 50 are more likely to have developed type 2 diabetes if they started antiretroviral treatment before 1999 or had a longer exposure to older antiretroviral drugs such as stavudine (d4T) or first-generation protease inhibitors such as nelfinavir or indinavir, according to a study of people receiving HIV care in British Columbia, Canada. The onset of diabetes was much less likely in people aged 50 and over who started treatment from 2010 onwards, or who started tr

It’s time to retire Canada’s AIDS epidemic

published: December, 01, 2017 Written by // Guest Authors - Revolving Door Categories // Social Media, As Prevention , CATIE, Treatment Guidelines -including when to start, General Health, Mental Health, Research, Health, CATIE - HIV and Hep C Info Resource, Revolving Door, Treatment, Media, Guest Authors, Opinion Pieces

For World AIDS Day 2017, PositiveLite.com is proud to present this guest editorial by CATIE Executive Director, Laurie Edmiston.

It’s time to retire Canada’s AIDS epidemic

Having turned 60 two months ago, I know there’s nothing quite like a milestone birthday to force you to get serious about your priorities and your future. The HIV response is facing our own wake-up call this December 1 as we mark the 30thWorld AIDS Day – a milestone I never imagined we would reach when I started working in HIV, 30 years ago. I have spent more than half of my life working in the HIV response, and while our goals have remained unchanged – reducing HIV infections and kee

Research finds that harm reduction and ART helped to reduce the spread of HIV in Vancouver

published: May, 02, 2017 Written by // CATIE - HIV and Hep C Info Resource Categories // Social Media, As Prevention , CATIE, Treatment Guidelines -including when to start, Health, Research, CATIE - HIV and Hep C Info Resource, Treatment

Sean R. Hosein of CATIE reports on research in Vancouver that attempted to study the relative impact that ART, harm reduction or both can have on the spread of HIV.

Research finds that harm reduction and ART helped to reduce the spread of HIV in Vancouver

In clinical trials, the early initiation of HIV treatment (ART) stabilizes the immune system and significantly reduces the risk of developing AIDS-related infections and cancers. This benefit of ART is so profound that researchers increasingly expect that many ART users will live into their senior years. Key to reaping the benefit of ART is achieving an undetectable level of HIV in the blood (viral load) and maintaining it through daily use of ART and regular checkups and laboratory monitori

B.C. researchers explore life expectancy among HIV-positive people

published: March, 30, 2017 Written by // CATIE - HIV and Hep C Info Resource Categories // Aging, Social Media, Hep B and C, General Health, Mental Health, Health, CATIE - HIV and Hep C Info Resource, Living with HIV, Media

From CATIE, Sean R. Hosein reports on studies comparing the effect of comorbidities on life expectancy in people living with HIV and those who are HIV-negative.

B.C. researchers explore life expectancy among HIV-positive people

In the 20th century, life expectancy increased in Canada and other high-income countries thanks to improvements in medicine, better living conditions and so on. These changes have led some researchers to focus on something called health-adjusted life expectancy: exploring the number of years a person can expect to live in good and bad health and taking into account age-related illness, death and disability. Among many HIV-positive people in Canada and other high-income countries there has be

High rates of injury found among some HIV-positive people in B.C.

published: January, 16, 2017 Written by // CATIE - HIV and Hep C Info Resource Categories // Social Media, CATIE, General Health, Mental Health, Health, Research, International , CATIE - HIV and Hep C Info Resource

CATIE reports on a study that undertook an assessment of rates and predictors of injury in HIV-positive and HIV-negative adults in British Columbia

High rates of injury found among some HIV-positive people in B.C.

Une version française est disponible ici.   In Canada and other high-income countries, the widespread use of potent combination HIV therapy (ART) has significantly reduced AIDS-related deaths and illness—at least among people who are aware of their infection, in care and taking ART every day exactly as prescribed and directed. Due to the tremendous life-saving effects of ART, researchers increasingly expect that a young adult who is infected today and who initiates treatment shortly t

The science-based U=U message is everywhere - but some aren’t biting.

published: December, 12, 2016 Written by // Bob Leahy - Publisher Categories // Activism, Social Media, As Prevention , Gay Men, Current Affairs, Treatment Guidelines -including when to start, Features and Interviews, Health, International , Treatment, Opinion Pieces, Bob Leahy - Publisher

Bob Leahy: Are organizations passing up on the chance to end HIV stigma and inform people living with HIV who are durably undetectable that they can’t transmit the virus? What people are saying

The science-based U=U message is everywhere - but some aren’t biting.

The images accompanying this article are from campaigns around the world informing people living with HIV that if their viral load is durably suppressed, they can not transmit the virus to others. There were no Canadian images used because no such campaigns exist in Canada.  It’s getting heated People living with HIV have never played a greater part in designing and implementing prevention messaging. In just a few months, the U = U message from the Prevention Access Campaign, arguably the

CPPN joins PositiveLite.com in endorsing Prevention Access Campaign’s Undetectable = Uninfectious message

published: September, 13, 2016 Written by // Bob Leahy - Publisher Categories // Social Media, Activism, As Prevention , Current Affairs, Treatment Guidelines -including when to start, Research, International , Legal, Treatment, Opinion Pieces, Bob Leahy - Publisher

Bob Leahy writes about the growing support in Canada for a science-based grass roots movement which has the potential to empower people living with HIV like never before, reduce stigma and contribute to the fight against criminalization

CPPN joins PositiveLite.com in endorsing Prevention Access Campaign’s Undetectable = Uninfectious message

Call it uninfectious, call it untransmittable. Bottom line is that HIV is not what it used to be. If you maintain an undetectable viral load you are not putting anyone else at risk. You cannot transmit the virus. That science-based conclusion is unusual in that its messenger is, this time, not conventionally funded AIDS organizations but those most affected - people living with HIV, like New York City’s Bruce Richman, a poz gay man whom I interviewed for PositiveLite.com here. He’s the c

PrEP vs TasP – it shouldn’t be a contest

Bob Leahy and the current debate around the use of PrEP. Has PrEP become the distraction that some warned against and are we forgetting the more readily available ways of stemming new infections waiting to be expanded, like testing and TasP?

PrEP vs TasP – it shouldn’t be a contest

The PrEP debate Anyone idly following the HIV press lately could be forgiven for thinking that pre-exposure prophylaxis (PrEP) is not just the latest big thing  in HIV prevention but the way we will end the epidemic. Single handedly. Forget condoms. Forget TasP. Forget PEP. Forget microbicides.  Forget cure research. PrEP is the answer – or so  it may seem to the casual observer Let’s say up front I’m a fan of PrEP. In fact PositiveLite.com has been a proponent since the early days

[12  >>